Abstract
Purpose: Electronic Nicotine Delivery Systems (ENDS) use among adolescents has increased greatly over the past decade, but its impact on chronic respiratory health conditions, like asthma, is not fully understood. Methods: We examined data from Waves 1–5 (2013–2019) of the Population Assessment of Tobacco and Health Study using discrete time hazard models to analyze the association between time-varying tobacco product use and incident diagnosed asthma among adolescents aged 12–17 years at baseline. We lagged the time-varying exposure variable by one wave and categorized respondents by current use status (1+ days in the past 30 days): never or non-current, exclusive cigarette, exclusive ENDS, and dual cigarette and ENDS use. We also controlled for sociodemographic (age, sex, race/ethnicity, parental education) and other risk factors (urban/rural setting, secondhand smoke exposure, household combustible tobacco use, body mass index). Results: At baseline, over half the analytic sample (n = 9,141) was 15–17 years old (50.4%), female (50.2%), and non-Hispanic White (55.3%). Adolescents who exclusively smoked cigarettes had a statistically significant higher risk of incident diagnosed asthma at follow-up (adjusted Hazard Ratio (aHR): 1.68, 95% confidence interval (CI): 1.21–2.32) compared to those not currently using cigarettes or ENDS, but adolescents using ENDS exclusively (aHR: 1.25, 95% CI: 0.77–2.04) or in combination with cigarettes (aHR: 1.54, 95% CI: 0.92–2.57) did not. Discussion: Short-term exclusive cigarette use was associated with a higher risk of incident diagnosed asthma over five years of follow-up among adolescents. We did not find conclusive evidence for an association between exclusive ENDS or dual use and incident diagnosed asthma.
Original language | English |
---|---|
Pages (from-to) | 437-444 |
Number of pages | 8 |
Journal | Journal of Adolescent Health |
Volume | 73 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2023 |
Bibliographical note
Funding Information:This work was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and the Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) under Award Number U54CA229974. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The opinions expressed in this work are the authors' own and do not reflect the views of the National Institutes of Health, the Food and Drug Administration, the Department of Health and Human Services, nor the United States government. Disclaimer: Preliminary findings were presented at the Society for Research on Nicotine and Tobacco Annual Meeting in March 2022, in Baltimore, Maryland.Conclusive findings were presented at the Fall 2022 Tobacco Centers of Regulatory Science Grantee Meeting in October 2022 virtually.
Funding Information:
This work was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and the Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) under Award Number U54CA229974. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The opinions expressed in this work are the authors' own and do not reflect the views of the National Institutes of Health, the Food and Drug Administration, the Department of Health and Human Services, nor the United States government.
Publisher Copyright:
© 2023 Society for Adolescent Health and Medicine
Keywords
- Adolescence
- Asthma
- Electronic nicotine delivery systems
- Epidemiology
- Smoking
- Tobacco
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health